We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Universal Iodine Supplementation Recommended During Pregnancy

By HospiMedica International staff writers
Posted on 17 Aug 2015
Giving all pregnant women iodine supplements, even in mildly iodine deficient countries, could result in huge cost savings for health care systems and society in general, according to a new study.

Researchers at the University of Birmingham (United Kingdom) and the National University of Singapore (NUS; Singapore) systematically searched MEDLINE, Embase, EconLit, and other sources for economic studies that linked IQ and income to investigate the cost-effectiveness of iodine supplementation for pregnant women in a mildly to moderately iodine-deficient population. More...
In all, 1,361 published articles were reviewed, and clinical data relating to iodine deficiency in pregnant women and the effect on IQ in their children were extracted.

A decision tree was developed to compare the treatment strategies of iodine supplementation in tablet form, compared to no iodine supplementation for pregnant women in the UK. Modeling analyses were then done from both a health service perspective and societal perspective, presented in terms of cost per IQ point gained in the offspring. Data-supported assumptions were used in a conservative approach, which limited the benefits of iodine supplementation and overestimated its potential harms.

The results estimated the lifetime value of an additional IQ point at GBP 3,297 for the offspring cohort. Iodine supplementation presented a cost saving from both a health service perspective (GBP 199 per pregnant woman), and societal perspective (GBP 4,476 per pregnant woman), based on a net gain of 1.22 IQ points. The estimates were derived from projected increased lifetime earnings and lower public sector costs. According to the researchers, the findings have implications for 1.88 billion people in the 32 countries with iodine deficiency. The study was published on August 9, 2015, in the Lancet Diabetes & Endocrinology.

“Iodine deficiency in pregnancy remains the leading cause of preventable retardation worldwide. Even mild iodine deficiency during pregnancy is associated with children with lower IQs,” said study coauthor Professor of Public Health Kate Jolly, PhD, of the University of Birmingham. “It's time for all women living in iodine deficient countries without universal supplementation of iodine, who are pregnant, breastfeeding, or planning a pregnancy to be advised to take a daily supplement containing iodine.”

Iodine is not produced naturally in the body and must be consumed by eating dairy and seafood, or by supplementation. Severe iodine deficiency during pregnancy can cause substantial mental impairment and delayed development in children, resulting in a lower IQ and consequently lower educational attainment and earning potential. International health organizations such as the World Health Organization (WHO; Geneva, Switzerland) the European Food Safety Authority (EFSA; Parma, Italy) recommend that pregnant and breastfeeding women take daily iodine supplements.

Related Links:

University of Birmingham
National University of Singapore
World Health Organization



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.